Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Matthias Rösslein, Neill J. Liptrott, Andrew Owen, Patrick Boisseau, Peter Wick, Inge K. Herrmann

Journal title: Nanotoxicology

Journal number: 11/2

Journal publisher: Informa Healthcare

Published year: 2017

Published pages: 147-149

DOI identifier: 10.1080/17435390.2017.1279361

ISSN: 1743-5390